Table 2.
Availability of infrastructure, equipment/supply and essential drugs to provide quality MNH care in the facility
| Input Quality items | Number of Health facilities that responded “YES” | % Health facilities (#32) |
|---|---|---|
| Infrastructure | ||
| Functional incinerator on the time of visit. | 26 | 81% |
| Functional placenta pit on the time of visit. | 30 | 94% |
| Electric power supplies any type. | 30 | 94% |
| Water availability in the compound either in the form of pipe water or hand pump. | 21 | 66% |
| Mean Infrastructure availability | 83.6% | |
| Health facilities with all infrastructure inputs available | 9 | 28% |
| Equipment/supply | ||
| Newborn corner in the delivery room. | 10 | 31% |
| Baby Weighing scales for Newborns with 50 precision. | 31 | 97% |
| Complete delivery sets (Kidney dish, forceps, gauze swabs, Scissors, pads, cord tie/clips) at least three per facility. | 29 | 91% |
| Towel for baby drying and wrapping | 4 | 13% |
| Bulb suction | 23 | 72% |
| Ambu bag & face masks (neonatal- size 0) | 12 | 38% |
| Ambu bag & face masks (neonatal- size 1) | 14 | 44% |
| Oxygen concentrator/Oxygen cylinder | 10 | 31% |
| Radiant warmer | 15 | 47% |
| Running water at the delivery room. | 9 | 34% |
| Soap at the delivery room. | 21 | 66% |
| Mean Equipment/supply availability | 46% | |
| Health facilities with all Equipment/supply inputs available | 0 | 0 |
| Essential drugs | ||
| • Dexamethasone/betamethasone IV | 13 | 41% |
| • Methyldopa | 23 | 72% |
| • Hydralazine | 24 | 75% |
| • Nifedipine | 21 | 66% |
| • Ampicillin (IV) | 26 | 81% |
| • Gentamycin (IV) | 30 | 94% |
| • Metronidazole (IV) | 18 | 56% |
| • TTC eye ointment | 30 | 94% |
| • Vitamin K | 28 | 88% |
| • MgSO4 | 23 | 72% |
| • Calcium gluconate | 10 | 31% |
| • Oxytocin | 31 | 97% |
| • Normal saline/Ringers lactate | 32 | 100% |
| Mean of essential drugs availability | 74% | |
| Health facilities with all essential drug inputs available | 3 | 9% |
| Overall Input Mean | 62% | |